- The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?2018 | Faculty of Medicine in Hradec Králové
- Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?Publication without faculty affiliation
- Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia2010 | Faculty of Medicine in Hradec Králové
- Evolocumab - novel options in the treatment of hyperlipidemia2016 | Faculty of Medicine in Hradec Králové
- Atherosclerotic cardiovascular diseases and clinical signifikance of treatment with inclisiran2021 | Faculty of Medicine in Hradec Králové
- What is the role of nutriceuticals in dyslipidemia management? Armolipid Plus +12017 | Faculty of Medicine in Pilsen
- Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial2014 | First Faculty of Medicine
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk +12009 | Faculty of Medicine in Hradec Králové
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Molecular Genetic Background of an Autosomal Dominant Hypercholesterolemia in the Czech Republic2017 | First Faculty of Medicine
- Pregnancy in homozygous familial hypercholesterolemia-A case series2022 | Faculty of Medicine in Hradec Králové
- A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey)2008 | Third Faculty of Medicine
- Obesity and Dyslipidemia2023 | Faculty of Medicine in Pilsen
- Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence2014 | First Faculty of Medicine
- Dyslipidemia and Cardiovascular Disease in Women2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial2016 | First Faculty of Medicine
- Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force2021 | First Faculty of Medicine
- Immediate effect of fluvastatin on lipid levels in acute coronary syndrome2007 | Third Faculty of Medicine
- Immediate effect of fluvastatin on lipid levels in acute coronary syndrome2007 | Second Faculty of Medicine
- The effect of amaranth flour on plasma cholesterol profile in mice with diet-induced dyslipidaemia2013 | Central Library of Charles University
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)2023 | First Faculty of Medicine
- The association between lipid parameters and obesity in university students2016 | Faculty of Medicine in Pilsen
- Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)2021 | First Faculty of Medicine
- The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice2014 | First Faculty of Medicine
- Cholesterol and cognitive performance among community volunteers from the Czech Republic2015 | Second Faculty of Medicine
- Effect of Hormone Replacement Therapy on the Cardiovascular System2002 | Central Library of Charles University, First Faculty of Medicine
- Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic2014 | Faculty of Pharmacy in Hradec Králové